The Poisons and Therapeutic Goods Act 1966 (NSW) and the Poisons and Therapeutic Goods Regulation 2008 (NSW)form the primary legislative framework that regulates the supply of medicines, poisons, and therapeutic goods in New South Wales.
This framework is scheduled to be replaced in 2026 by the Medicines, Poisons and Therapeutic Goods Act 2022 (NSW) (the Act), which was passed in NSW Parliament in November 2022, along with the Medicines, Poisons and Therapeutic Goods Regulation, expected to also be finalised in 2026 once approved by the Minister.
Once a commencement date of the Act and Regulation is set, Pharmaceutical Services will work closely with stakeholders to raise awareness of the legislative changes relevant to each profession and area of practice. Updates will be posted on this page.
NSW Health is seeking expressions of interest (EOI) for membership of the new statutory committees that are to be established under the Medicines, Poisons, and Therapeutic Goods Act 2022. These committees include the Regulatory Advisory Committee and Clinical Advisory Committee and these will be establised on commencement of the Act.